Question 9 Answer saved Marked out of 1.00 Cipra Inc. is a large, publicly traded pharmaceutical company with 100 million shares outstanding, trading at $ 20/share. It has just announced an acquisition bid at $15 share, for Lexma Inc., a smaller pharmaceutical company, with 50 million shares, currently trading at $10 a share, arguing that the premium is justified by the synergy in the deal. If Cipra's stock price drops to $18/share after the bid is announced and the market is right, estimate the synergy that the market expects from the deal, i.e. what is the net gain/loss from the above P Flag question transaction? O a. b.-$200 million b. a $250 million O c. d. 5100 million O d. e. Impossible to tell O e. c. 550 million Clear my choice Give your reasons 2 " III 3 Question 10 You are a bank that has made a fixed rate, long-term loan to a publicly traded company. The company has a significant cash balance and is under pressure to act. Which of the following actions would you view as favorable